Metered Dose Inhaler Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021

All the vital news, analysis, and commentary curated by our industry experts.

$2500

Buy Report View Sample

Published: July 30, 2021 Report Code: GDME1138EPD-ST

Report Overview
Key Players
Table of Contents
Table
Figures

Metered Dose Inhaler Devices delivers a specific amount of medication to lungs and GI tract. It is mostly used by asthma and COPD patients. GlobalData's Medical Devices sector report, “Metered Dose Inhaler Devices – Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Metered Dose Inhaler Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Metered Dose Inhaler Devices report provides key information and data related to:
Extensive coverage of the Metered Dose Inhaler Devices under development
Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates
Reviews of major players involved in the pipeline product development.
Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Metered Dose Inhaler Devices pipeline products.
Review of Recent Developments in the segment / industry
The Metered Dose Inhaler Devices report enables you to:
Access significant competitor information, analysis, and insights to improve your R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Metered Dose Inhaler Devices under development
Formulate market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
The major companies covered in the “Metered Dose Inhaler Devices – Medical Devices Pipeline Product Landscape, 2021” report:
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports
• 64,000+ medical equipment company profiles
• 5,600+ company profiles of medical equipment manufacturers in China and India
• 2,200+ company profiles of medical equipment manufacturers in Japan
• 1,200+ companies’ revenue splits and market shares
• 1,600+ quarterly and annual medical equipment company financials
• 850+ medical equipment company SWOTs
• 28,000+ pipeline product profiles
• 56,400+ marketed product profiles
• 47,000+ clinical trials
• 41,500+ trial investigators
• 7,000+ reports on companies with products in development
• 44,000+ deals in the medical equipment industry
• 1,100+ surgical and diagnostic procedures by therapy area
• 50+ key healthcare indicators by country
• 431,000+ Themes Content Items
• 600+ Influencers
• 1,900+ Analysts & Researchers
• 0.5m+ Community Members
• 141,000+ Macroeconomic Indicators
• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:
https://medical.globaldata.com/home.aspx
Custom Requirements
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs

Scope

Extensive coverage of the Metered Dose Inhaler Devices under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Metered Dose Inhaler Devices and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

– Identify and understand important and diverse types of Metered Dose Inhaler Devices under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Adamis Pharmaceuticals Corp
Aeropharm GmbH
Aerophase Inc
Bespak Europe Ltd
Circassia Group Plc
Globe Medical Tech Inc (Inactive)
GoFire Inc
Lab Automate Technologies Inc
Lupin Pharmaceuticals Inc
Medicom Innovation Partner a/s
Nemera La Verpilliere
Pearl Therapeutics Inc
Rapid Therapeutic Science Laboratories Inc
Reciprocal Labs Corp
Rensselaer Polytechnic Institute
TM Global Bioscience LLC
Vectura Group Plc
Verona Pharma Plc

1 Table of Contents

2 Introduction 8

2.1 Metered Dose Inhaler Devices Overview 8

3 Products under Development 9

3.1 Metered Dose Inhaler Devices – Pipeline Products by Stage of Development 9

3.2 Metered Dose Inhaler Devices – Pipeline Products by Territory 10

3.3 Metered Dose Inhaler Devices – Pipeline Products by Regulatory Path 11

3.4 Metered Dose Inhaler Devices – Pipeline Products by Estimated Approval Date 12

3.5 Metered Dose Inhaler Devices – Ongoing Clinical Trials 13

4 Metered Dose Inhaler Devices – Pipeline Products under Development by Companies 14

4.1 Metered Dose Inhaler Devices Companies – Pipeline Products by Stage of Development 14

4.2 Metered Dose Inhaler Devices – Pipeline Products by Stage of Development 15

5 Metered Dose Inhaler Devices Companies and Product Overview 16

5.1 Adamis Pharmaceuticals Corp Company Overview 16

5.1.1 Adamis Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 16

5.2 Aeropharm GmbH Company Overview 17

5.2.1 Aeropharm GmbH Pipeline Products & Ongoing Clinical Trials Overview 17

5.3 Aerophase Inc Company Overview 18

5.3.1 Aerophase Inc Pipeline Products & Ongoing Clinical Trials Overview 18

5.4 Bespak Europe Ltd Company Overview 20

5.4.1 Bespak Europe Ltd Pipeline Products & Ongoing Clinical Trials Overview 20

5.5 Circassia Group Plc Company Overview 21

5.5.1 Circassia Group Plc Pipeline Products & Ongoing Clinical Trials Overview 21

5.6 Globe Medical Tech Inc (Inactive) Company Overview 22

5.6.1 Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 22

5.7 GoFire Inc Company Overview 23

5.7.1 GoFire Inc Pipeline Products & Ongoing Clinical Trials Overview 23

5.8 Lab Automate Technologies Inc Company Overview 24

5.8.1 Lab Automate Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 24

5.9 Lupin Pharmaceuticals Inc Company Overview 25

5.9.1 Lupin Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 25

5.10 Medicom Innovation Partner a/s Company Overview 26

5.10.1 Medicom Innovation Partner a/s Pipeline Products & Ongoing Clinical Trials Overview 26

5.11 Nemera La Verpilliere Company Overview 27

5.11.1 Nemera La Verpilliere Pipeline Products & Ongoing Clinical Trials Overview 27

5.12 Pearl Therapeutics Inc Company Overview 28

5.12.1 Pearl Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.13 Rapid Therapeutic Science Laboratories Inc Company Overview 30

5.13.1 Rapid Therapeutic Science Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 30

5.14 Reciprocal Labs Corp Company Overview 33

5.14.1 Reciprocal Labs Corp Pipeline Products & Ongoing Clinical Trials Overview 33

5.15 Rensselaer Polytechnic Institute Company Overview 34

5.15.1 Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 34

5.16 TM Global Bioscience LLC Company Overview 35

5.16.1 TM Global Bioscience LLC Pipeline Products & Ongoing Clinical Trials Overview 35

5.17 Vectura Group Plc Company Overview 36

5.17.1 Vectura Group Plc Pipeline Products & Ongoing Clinical Trials Overview 36

5.18 Verona Pharma Plc Company Overview 37

5.18.1 Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview 37

6 Metered Dose Inhaler Devices- Recent Developments 40

6.1 Jul 21, 2021: Novartis Announces Q2 2021 Financial Results 40

6.2 Jul 08, 2021: H&T Presspart Tarragona open State-Of-The-Art offices 42

6.3 Jun 08, 2021: Desert Oasis Healthcare, Propeller Health expand partnership to improve outcomes for asthma and COPD patients 43

6.4 Apr 29, 2021: Merck Announces First-Quarter 2021 Financial Results 43

6.5 Apr 29, 2021: Viatris to Participate in BofA Securities 2021 Health Care Conference 43

6.6 Apr 27, 2021: Novartis key growth drivers and launches continue momentum in Q1, maintaining confidence in growth. Group guidance for FY 2021 confirmed 44

6.7 Apr 12, 2021: Viatris to Release First Quarter 2021 Financial Results on May 10, 2021 47

6.8 Mar 29, 2021: Merck to Hold First-Quarter 2021 Sales and Earnings Conference Call on April 29 47

6.9 Mar 22, 2021: Novartis appoints Karen Hale as Chief Legal Officer 47

6.10 Mar 04, 2021: Viatris to Participate in Barclays Global Healthcare Conference 48

6.11 Mar 03, 2021: Merck to Present at the Barclays Global Healthcare Conference 48

6.12 Feb 24, 2021: Merck to Present at the Cowen 41st Annual Health Care Conference 48

6.13 Feb 11, 2021: Acknowledged scientific leader and Novartis veteran joins Sai Life Sciences 49

6.14 Feb 05, 2021: Merck CFO Brings Corporate Strategy Experience to CEO Role 49

6.15 Jan 12, 2021: Vectura Group: Trading update 49

6.16 Sep 24, 2020: H&T Presspart: Revolutionising Medical Cannabis Drug Delivery Webinar 51

6.17 Sep 01, 2020: Novartis announces ambitious ESG targets to increase access to medicines and achieve full carbon neutrality 51

7 Appendix 53

7.1 Methodology 53

7.2 About GlobalData 56

7.3 Contact Us 56

Table

Metered Dose Inhaler Devices – Pipeline Products by Stage of Development 9

Metered Dose Inhaler Devices – Pipeline Products by Territory 10

Metered Dose Inhaler Devices – Pipeline Products by Regulatory Path 11

Metered Dose Inhaler Devices – Pipeline Products by Estimated Approval Date 12

Metered Dose Inhaler Devices – Ongoing Clinical Trials 13

Metered Dose Inhaler Devices Companies – Pipeline Products by Stage of Development 14

Metered Dose Inhaler Devices – Pipeline Products by Stage of Development 15

Adamis Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 16

APC-1000 Beclomethasone Metered Dose Inhaler – Product Status 16

APC-1000 Beclomethasone Metered Dose Inhaler – Product Description 16

Aeropharm GmbH Pipeline Products & Ongoing Clinical Trials Overview 17

VAL050 pMDI Valve / Actuator – Product Status 17

VAL050 pMDI Valve / Actuator – Product Description 17

Aerophase Inc Pipeline Products & Ongoing Clinical Trials Overview 18

Aerosol-Delivery System – NTM Respiratory Infection – Product Status 18

Aerosol-Delivery System – NTM Respiratory Infection – Product Description 18

Metered Dose Inhaler – Product Status 19

Metered Dose Inhaler – Product Description 19

Bespak Europe Ltd Pipeline Products & Ongoing Clinical Trials Overview 20

VAL020 Metered Dose Inhaler Valve – Product Status 20

VAL020 Metered Dose Inhaler Valve – Product Description 20

Circassia Group Plc Pipeline Products & Ongoing Clinical Trials Overview 21

Fluticasone propionate/Salmeterol xinafoate pMDI – Product Status 21

Fluticasone propionate/Salmeterol xinafoate pMDI – Product Description 21

Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 22

Inhaler – Product Status 22

Inhaler – Product Description 22

GoFire Inc Pipeline Products & Ongoing Clinical Trials Overview 23

Gofire Inhaler – Product Status 23

Gofire Inhaler – Product Description 23

Lab Automate Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 24

Ultrasonic Metered Dose Inhaler – Product Status 24

Ultrasonic Metered Dose Inhaler – Product Description 24

Lupin Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 25

Albuterol MDI – Product Status 25

Albuterol MDI – Product Description 25

Medicom Innovation Partner a/s Pipeline Products & Ongoing Clinical Trials Overview 26

Asmair – Product Status 26

Asmair – Product Description 26

Nemera La Verpilliere Pipeline Products & Ongoing Clinical Trials Overview 27

RetroNose – Product Status 27

RetroNose – Product Description 27

Pearl Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 28

PT001 – Product Status 28

PT001 – Product Description 28

PT010 – Product Status 29

PT010 – Product Description 29

Rapid Therapeutic Science Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 30

Rxoid – Product Status 30

Rxoid – Product Description 30

Rapid Therapeutic Science Laboratories Inc – Ongoing Clinical Trials Overview 31

Rxoid – A Study to Evaluate the Rxoid Metered Dose Inhaler (MDI) Technology to Deliver Cannabinoid Compounds in Patients with Anxiety 32

Reciprocal Labs Corp Pipeline Products & Ongoing Clinical Trials Overview 33

Connected Metered Dose Inhaler – Product Status 33

Connected Metered Dose Inhaler – Product Description 33

Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 34

Bloom Inhaler – Product Status 34

Bloom Inhaler – Product Description 34

TM Global Bioscience LLC Pipeline Products & Ongoing Clinical Trials Overview 35

ApelinDx – Product Status 35

ApelinDx – Product Description 35

Vectura Group Plc Pipeline Products & Ongoing Clinical Trials Overview 36

Flutiform pMDI – Product Status 36

Flutiform pMDI – Product Description 36

Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview 37

RPL554 – Metered Dose Inhaler – Product Status 37

RPL554 – Metered Dose Inhaler – Product Description 37

Verona Pharma Plc – Ongoing Clinical Trials Overview 38

RPL554 – Metered Dose Inhaler – A Single-center, Pilot, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ensifentrine in the Recovery of Hospitalized Patients with Covid-19 39

Figures

Metered Dose Inhaler Devices – Pipeline Products by Stage of Development 9

Metered Dose Inhaler Devices – Pipeline Products by Territory 10

Metered Dose Inhaler Devices – Pipeline Products by Regulatory Path 11

Metered Dose Inhaler Devices – Pipeline Products by Estimated Approval Date 12

Frequently asked questions

Metered Dose Inhaler Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 standard reports

Currency USD

Single User

$2,500

Can be used by individual purchaser only

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Metered Dose Inhaler Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

Assess the relevance of the report
Evaluate the quality of the report
Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more Drug Delivery Devices reports

Medical Devices

New

PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…

Medical Devices

New

PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…

Medical Devices

New

Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…

Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Metered Dose Inhaler Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 in real time.

Access a live Metered Dose Inhaler Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 dashboard for 12 months, with up-to-the-minute insights.
Fuel your decision making with real-time deal coverage and media activity.
Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.

Tell me more

Reports

Reports by Sector

Report Type

Metered Dose Inhaler Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021

Scope

Reasons to Buy

Table of Contents

Table

Figures

Frequently asked questions

Undecided about purchasing this report?

Get in touch to find out about multi-purchase discounts

Sample Report

Below is a sample report to understand what you are buying

Related reports